美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
40450 A II 2024/08/31 VAMSI LABS LTD FORMOTEROL FUMARATE DIHYDRATE EP
40235 A II 2024/08/31 METROCHEM API PRIVATE LTD NICARDIPINE HYDROCHLORIDE USP
40263 A II 2024/08/31 MAITHRI DRUGS PRIVATE LTD FINERENONE
40267 A II 2024/08/31 HETERO LABS LTD VERICIGUAT (FORM-I)
40407 A II 2024/08/30 HENAN LIHUA PHARMACEUTICAL CO LTD MOMETASONE FUROATE PRECESS B
40440 A III 2024/08/30 ZHEJIANG HUAHAI PHARMACEUTICAL PACKAGING PRODUCTS CO LTD HDPE BOTTLES (60 CC & 120 CC)
40444 A IV 2024/08/30 AQUADRY PHARMA PVT LTD AQUADRY PGS (PREGELATINISED STARCH USP-NF/PH. EUR.)
39767 A II 2024/08/30 PURISYS LLC NALMEFENE HYDROCHLORIDE DRUG SUBSTANCE
40002 A IV 2024/08/30 CELANESE CANADA ULC ETHYLENE VINYL ACETATE COPOLYMER VITALDOSE K3240.X01
39422 A II 2024/08/30 NANJING VAZYME BIOTECH CO LTD VACCINIA CAPPING ENZYME
40214 A II 2024/08/30 QILU PHARMACEUTICAL CO LTD ARIPIPRAZOLE MONOHYDRATE (STERILE)
40227 A II 2024/08/30 CURIA ITALY SRL ARGATROBAN MONOHYDRATE
40259 A II 2024/08/30 SYNAFFIX BV UDP-AZIDOSUGAR
40315 A II 2024/08/30 SHANDONG ANHONG PHARMACEUTICAL CO LTD ABEMACICLIB
40336 A II 2024/08/29 QILU PHARMACEUTICAL CO LTD (LAOLING SITE) ARIPIPRAZOLE
40376 A II 2024/08/29 RUYUAN HEC PHARM CO LTD VONOPRAZAN FUMARATE NON-STERILE BULK DRUG SUBSTANCE
40424 A III 2024/08/29 WHITE PACKAGING PVT LTD PLAIN & PRINTED BLISTER, STRIP, ALU-ALU FOIL, MULTILAYER LAMINATES, SPECIALIZED PHARMA STRUCTURES AND HOLOGRAPHIC SECURITY FEATURES THROUGH PRINTING AND SLITTING FOR PHARMACEUTICAL INDUSTRIES
40425 A III 2024/08/29 NORTH EAST PHARMA PACK PLAIN & PRINTED BLISTER, STRIP, ALU-ALU FOIL, MULTILAYER LAMINATES, SPECIALIZED PHARMA STRUCTURES AND HOLOGRAPHIC SECURITY FEATURES THROUGH PRINTING AND SLITTING FOR PHARMACEUTICAL INDUSTRIES
40431 A II 2024/08/29 SHANGHAI SYNTHEALL PHARMACEUTICAL CO LTD VAL-CIT-PAB-MMAE
40438 A II 2024/08/29 UNICHEM LABORATORIES LTD AMLODIPINE BESYLATE (ADP PROCESS) USP

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files